Related Experiment Video

Updated: Jun 4, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Current Italian practices regarding the management of hyperbilirubinaemia in preterm infants

Carlo Dani1, Chiara Poggi, Jacopo Barp

  • 1Section of Neonatology, Department of Surgical and Medical Critical Care, Careggi University Hospital of Florence, Italy. cdani@unifi.It

Acta Paediatrica (Oslo, Norway : 1992)
|February 15, 2011
PubMed

Insights

Management of jaundice in preterm infants varies across Italy. National guidelines and a kernicterus registry are needed to standardize care and improve outcomes for hyperbilirubinaemia in these vulnerable infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Public Health

Background:

  • Hyperbilirubinaemia is a common condition in preterm infants.
  • Current management practices for jaundice in preterm infants in Italy lack uniformity.
  • There is a need for standardized national guidelines and a kernicterus registry.

Purpose of the Study:

  • To assess current jaundice management practices in Italian neonatal units.
  • To identify variations in total bilirubin monitoring and treatment protocols.
  • To lay the groundwork for national guidelines and a kernicterus registry.

Main Methods:

  • A questionnaire was distributed to 109 level III neonatal units in Italy.
  • The survey focused on guidelines for bilirubin monitoring and hyperbilirubinaemia treatment in preterm infants.
  • Data on kernicterus occurrence was also collected.

Main Results:

  • A 61% response rate was achieved.
  • 85% of units reported having written guidelines for jaundice management.
  • Significant variability was observed in bilirubin monitoring timing and treatment thresholds.
  • Phototherapy and exchange transfusion rates were reported.
  • Kernicterus cases in both preterm and term infants were documented over 10 years.

Conclusions:

  • Jaundice management in preterm infants is inconsistent across Italy.
  • Shared national guidance is essential for optimizing therapy.
  • Establishing a kernicterus registry is crucial for data collection and guiding future interventions.
Abstract

More Related Videos

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...